News
Return on investment in pharma R&D rises with GLP-1 drugs helping drive growth
The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs helping to boost growth, according...
Chlamydia vaccine candidate granted US FDA fast track designation
The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision...
Augustine Therapeutics raises €78m
Augustine Therapeutics, a biotechnology company focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase...
